Search

Search bills, members, committees and pages...

Sign In

DANIELLE MITCHELL

PreviousNext

12 federal lobbying filings, 2023 to 2025.

DANIELLE MITCHELL is a registered lobbyist named on 12 federal lobbying filings, 2023 to 2025.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 they have filed under, by filings.

RegistrantFilingsReported
ABIOMED, INC7—
JOHNSON & JOHNSON SERVICES, INC.5—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20253—$6.9M
20245—$4.3M
20234—$640K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues12
BUDBudget/Appropriations5
CPTCopyright/Patent/Trademark5
LAWLaw Enforcement/Crime/Criminal Justice5
PHAPharmacy5
SCIScience/Technology5
TAXTaxation/Internal Revenue Code5
VETVeterans5
BNKBankruptcy2
CSPConsumer Issues/Safety/Products2
ENVEnvironment/Superfund2
LBRLabor Issues/Antitrust/Workplace2
MMMMedicare/Medicaid2
TRDTrade (domestic/foreign)2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1109Litigation Transparency Act of 20253
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…3
H.R. 1539Medical Device Electronic Labeling Act3
H.R. 2214DRUG Act3
H.R. 946ORPHAN Cures Act3
H.Res. 1301Supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awarenes…3
S. 1040Drug Competition Enhancement Act3
S. 1041Affordable Prescriptions for Patients Act3
S. 1097Interagency Patent Coordination and Improvement Act of 20253
S. 266Dr. Lorna Breen Health Care Provider Protection Reauthorization Act3
S. 832EPIC Act of 20253
S. 864HELP Copays Act3
H.R. 2527Early Detection of Vision Impairments for Children Act of 20252
S. 1954Biosimilar Red Tape Elimination Act2
H.R. 2675Protecting Our Courts from Foreign Manipulation Act1
H.R. 3269ETHIC Act1
H.R. 4282Contact Lens Prescription Verification Modernization Act1
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act1
H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act1
H.R. 5526Biosimilar Red Tape Elimination Act1
H.R. 929Dr. Lorna Breen Health Care Provider Protection Reauthorization Act1
S. 1717Ensuring Patient Access to Critical Breakthrough Products Act of 20251
S. 2276ETHIC Act1
S. 2658Medication Affordability and Patent Integrity Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 third_quarter$2.5MOct 20, 2025
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 second_quarter$1MJul 21, 2025
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 first_quarter$3.3MApr 21, 2025
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2024 fourth_quarter$1.5MJan 21, 2025
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2024 third_quarter$2.3MOct 21, 2024
ABIOMED, INCABIOMED, INC2024 third_quarter$160KOct 18, 2024
ABIOMED, INCABIOMED, INC2024 second_quarter$160KJul 17, 2024
ABIOMED, INCABIOMED, INC2024 first_quarter$160KApr 18, 2024
ABIOMED, INCABIOMED, INC2023 fourth_quarter$170KJan 19, 2024
ABIOMED, INCABIOMED, INC2023 third_quarter$160KOct 17, 2023
ABIOMED, INCABIOMED, INC2023 second_quarter$160KJul 17, 2023
ABIOMED, INCABIOMED, INC2023 first_quarter$150KApr 19, 2023